Here, we provide solid evidence that celecoxib reduces lipogenesis‐triggered hepatic steatosis in AKT‐transfected mice, accompanied by the suppression of hepatocellular inflammatory responses (TNF‐α, IL‐6 and IL‐1β). The gene discussed is AKT1; the disease is fatty liver disease.